Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS

Identifieur interne : 000E93 ( Pmc/Curation ); précédent : 000E92; suivant : 000E94

A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS

Auteurs : A M. Wills ; S. Cronin ; A. Slowik ; D. Kasperaviciute ; M A. Van Es ; J M. Morahan ; P N. Valdmanis ; V. Meininger ; J. Melki ; C E. Shaw ; G A. Rouleau ; E M. C. Fisher ; P J. Shaw ; K E. Morrison ; R. Pamphlett ; L H. Van Den Berg ; D A. Figlewicz ; P M. Andersen ; A. Al-Chalabi ; O. Hardiman ; S. Purcell ; J E. Landers ; R H. Brown

Source :

RBID : PMC:2707108

Abstract

Background:

Six candidate gene studies report a genetic association of DNA variants within the paraoxonase locus with sporadic amyotrophic lateral sclerosis (ALS). However, several other large studies, including five genome-wide association studies, have not duplicated this finding.

Methods:

We conducted a meta-analysis of 10 published studies and one unpublished study of the paraoxonase locus, encompassing 4,037 ALS cases and 4,609 controls, including genome-wide association data from 2,018 ALS cases and 2,425 controls.

Results:

The combined fixed effects odds ratio (OR) for rs662 (PON1 Q192R) was 1.09 (95% confidence interval [CI], 1.02–1.16, p = 0.01); the genotypic OR for RR homozygotes at Q192R was 1.25 (95% CI, 1.07–1.45, p = 0.0004); the combined OR for rs854560 (PON1 L55M) was 0.97 (95% CI, 0.86–1.10, p = 0.62); the OR for rs10487132 (PON2) was 1.08 (95% CI, 0.92–1.27, p = 0.35). Although the rs662 polymorphism reached a nominal level of significance, no polymorphism was significant after multiple testing correction. In the subanalysis of samples with genome-wide data from which population outliers were removed, rs662 had an OR of 1.06 (95% CI, 0.97–1.16, p = 0.22).

Conclusions:

In contrast to previous positive smaller studies, our genetic meta-analysis showed no significant association of amyotrophic lateral sclerosis (ALS) with the PON locus. This is the largest meta-analysis of a candidate gene in ALS to date and the first ALS meta-analysis to include data from whole genome association studies. The findings reinforce the need for much larger and more collaborative investigations of the genetic determinants of ALS.

GLOSSARYALS

= amyotrophic lateral sclerosis;

CI

= confidence interval;

GWAS

= genome-wide association studies;

OR

= odds ratio;

SALS

= sporadic ALS;

SNP

= single nucleotide polymorphism.


Url:
DOI: 10.1212/WNL.0b013e3181a18674
PubMed: 19321847
PubMed Central: 2707108

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:2707108

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS</title>
<author>
<name sortKey="Wills, A M" sort="Wills, A M" uniqKey="Wills A" first="A M." last="Wills">A M. Wills</name>
</author>
<author>
<name sortKey="Cronin, S" sort="Cronin, S" uniqKey="Cronin S" first="S" last="Cronin">S. Cronin</name>
</author>
<author>
<name sortKey="Slowik, A" sort="Slowik, A" uniqKey="Slowik A" first="A" last="Slowik">A. Slowik</name>
</author>
<author>
<name sortKey="Kasperaviciute, D" sort="Kasperaviciute, D" uniqKey="Kasperaviciute D" first="D" last="Kasperaviciute">D. Kasperaviciute</name>
</author>
<author>
<name sortKey="Van Es, M A" sort="Van Es, M A" uniqKey="Van Es M" first="M A." last="Van Es">M A. Van Es</name>
</author>
<author>
<name sortKey="Morahan, J M" sort="Morahan, J M" uniqKey="Morahan J" first="J M." last="Morahan">J M. Morahan</name>
</author>
<author>
<name sortKey="Valdmanis, P N" sort="Valdmanis, P N" uniqKey="Valdmanis P" first="P N." last="Valdmanis">P N. Valdmanis</name>
</author>
<author>
<name sortKey="Meininger, V" sort="Meininger, V" uniqKey="Meininger V" first="V" last="Meininger">V. Meininger</name>
</author>
<author>
<name sortKey="Melki, J" sort="Melki, J" uniqKey="Melki J" first="J" last="Melki">J. Melki</name>
</author>
<author>
<name sortKey="Shaw, C E" sort="Shaw, C E" uniqKey="Shaw C" first="C E." last="Shaw">C E. Shaw</name>
</author>
<author>
<name sortKey="Rouleau, G A" sort="Rouleau, G A" uniqKey="Rouleau G" first="G A." last="Rouleau">G A. Rouleau</name>
</author>
<author>
<name sortKey="Fisher, E M C" sort="Fisher, E M C" uniqKey="Fisher E" first="E M. C." last="Fisher">E M. C. Fisher</name>
</author>
<author>
<name sortKey="Shaw, P J" sort="Shaw, P J" uniqKey="Shaw P" first="P J." last="Shaw">P J. Shaw</name>
</author>
<author>
<name sortKey="Morrison, K E" sort="Morrison, K E" uniqKey="Morrison K" first="K E." last="Morrison">K E. Morrison</name>
</author>
<author>
<name sortKey="Pamphlett, R" sort="Pamphlett, R" uniqKey="Pamphlett R" first="R" last="Pamphlett">R. Pamphlett</name>
</author>
<author>
<name sortKey="Van Den Berg, L H" sort="Van Den Berg, L H" uniqKey="Van Den Berg L" first="L H." last="Van Den Berg">L H. Van Den Berg</name>
</author>
<author>
<name sortKey="Figlewicz, D A" sort="Figlewicz, D A" uniqKey="Figlewicz D" first="D A." last="Figlewicz">D A. Figlewicz</name>
</author>
<author>
<name sortKey="Andersen, P M" sort="Andersen, P M" uniqKey="Andersen P" first="P M." last="Andersen">P M. Andersen</name>
</author>
<author>
<name sortKey="Al Chalabi, A" sort="Al Chalabi, A" uniqKey="Al Chalabi A" first="A" last="Al-Chalabi">A. Al-Chalabi</name>
</author>
<author>
<name sortKey="Hardiman, O" sort="Hardiman, O" uniqKey="Hardiman O" first="O" last="Hardiman">O. Hardiman</name>
</author>
<author>
<name sortKey="Purcell, S" sort="Purcell, S" uniqKey="Purcell S" first="S" last="Purcell">S. Purcell</name>
</author>
<author>
<name sortKey="Landers, J E" sort="Landers, J E" uniqKey="Landers J" first="J E." last="Landers">J E. Landers</name>
</author>
<author>
<name sortKey="Brown, R H" sort="Brown, R H" uniqKey="Brown R" first="R H." last="Brown">R H. Brown</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">19321847</idno>
<idno type="pmc">2707108</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707108</idno>
<idno type="RBID">PMC:2707108</idno>
<idno type="doi">10.1212/WNL.0b013e3181a18674</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001032</idno>
<idno type="wicri:Area/Pmc/Curation">000E93</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000E93</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS</title>
<author>
<name sortKey="Wills, A M" sort="Wills, A M" uniqKey="Wills A" first="A M." last="Wills">A M. Wills</name>
</author>
<author>
<name sortKey="Cronin, S" sort="Cronin, S" uniqKey="Cronin S" first="S" last="Cronin">S. Cronin</name>
</author>
<author>
<name sortKey="Slowik, A" sort="Slowik, A" uniqKey="Slowik A" first="A" last="Slowik">A. Slowik</name>
</author>
<author>
<name sortKey="Kasperaviciute, D" sort="Kasperaviciute, D" uniqKey="Kasperaviciute D" first="D" last="Kasperaviciute">D. Kasperaviciute</name>
</author>
<author>
<name sortKey="Van Es, M A" sort="Van Es, M A" uniqKey="Van Es M" first="M A." last="Van Es">M A. Van Es</name>
</author>
<author>
<name sortKey="Morahan, J M" sort="Morahan, J M" uniqKey="Morahan J" first="J M." last="Morahan">J M. Morahan</name>
</author>
<author>
<name sortKey="Valdmanis, P N" sort="Valdmanis, P N" uniqKey="Valdmanis P" first="P N." last="Valdmanis">P N. Valdmanis</name>
</author>
<author>
<name sortKey="Meininger, V" sort="Meininger, V" uniqKey="Meininger V" first="V" last="Meininger">V. Meininger</name>
</author>
<author>
<name sortKey="Melki, J" sort="Melki, J" uniqKey="Melki J" first="J" last="Melki">J. Melki</name>
</author>
<author>
<name sortKey="Shaw, C E" sort="Shaw, C E" uniqKey="Shaw C" first="C E." last="Shaw">C E. Shaw</name>
</author>
<author>
<name sortKey="Rouleau, G A" sort="Rouleau, G A" uniqKey="Rouleau G" first="G A." last="Rouleau">G A. Rouleau</name>
</author>
<author>
<name sortKey="Fisher, E M C" sort="Fisher, E M C" uniqKey="Fisher E" first="E M. C." last="Fisher">E M. C. Fisher</name>
</author>
<author>
<name sortKey="Shaw, P J" sort="Shaw, P J" uniqKey="Shaw P" first="P J." last="Shaw">P J. Shaw</name>
</author>
<author>
<name sortKey="Morrison, K E" sort="Morrison, K E" uniqKey="Morrison K" first="K E." last="Morrison">K E. Morrison</name>
</author>
<author>
<name sortKey="Pamphlett, R" sort="Pamphlett, R" uniqKey="Pamphlett R" first="R" last="Pamphlett">R. Pamphlett</name>
</author>
<author>
<name sortKey="Van Den Berg, L H" sort="Van Den Berg, L H" uniqKey="Van Den Berg L" first="L H." last="Van Den Berg">L H. Van Den Berg</name>
</author>
<author>
<name sortKey="Figlewicz, D A" sort="Figlewicz, D A" uniqKey="Figlewicz D" first="D A." last="Figlewicz">D A. Figlewicz</name>
</author>
<author>
<name sortKey="Andersen, P M" sort="Andersen, P M" uniqKey="Andersen P" first="P M." last="Andersen">P M. Andersen</name>
</author>
<author>
<name sortKey="Al Chalabi, A" sort="Al Chalabi, A" uniqKey="Al Chalabi A" first="A" last="Al-Chalabi">A. Al-Chalabi</name>
</author>
<author>
<name sortKey="Hardiman, O" sort="Hardiman, O" uniqKey="Hardiman O" first="O" last="Hardiman">O. Hardiman</name>
</author>
<author>
<name sortKey="Purcell, S" sort="Purcell, S" uniqKey="Purcell S" first="S" last="Purcell">S. Purcell</name>
</author>
<author>
<name sortKey="Landers, J E" sort="Landers, J E" uniqKey="Landers J" first="J E." last="Landers">J E. Landers</name>
</author>
<author>
<name sortKey="Brown, R H" sort="Brown, R H" uniqKey="Brown R" first="R H." last="Brown">R H. Brown</name>
</author>
</analytic>
<series>
<title level="j">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<idno type="eISSN">1526-632X</idno>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background:</title>
<p>Six candidate gene studies report a genetic association of DNA variants within the paraoxonase locus with sporadic amyotrophic lateral sclerosis (ALS). However, several other large studies, including five genome-wide association studies, have not duplicated this finding.</p>
</sec>
<sec>
<title>Methods:</title>
<p>We conducted a meta-analysis of 10 published studies and one unpublished study of the paraoxonase locus, encompassing 4,037 ALS cases and 4,609 controls, including genome-wide association data from 2,018 ALS cases and 2,425 controls.</p>
</sec>
<sec>
<title>Results:</title>
<p>The combined fixed effects odds ratio (OR) for rs662 (PON1 Q192R) was 1.09 (95% confidence interval [CI], 1.02–1.16,
<italic>p</italic>
= 0.01); the genotypic OR for RR homozygotes at Q192R was 1.25 (95% CI, 1.07–1.45,
<italic>p</italic>
= 0.0004); the combined OR for rs854560 (PON1 L55M) was 0.97 (95% CI, 0.86–1.10,
<italic>p</italic>
= 0.62); the OR for rs10487132 (PON2) was 1.08 (95% CI, 0.92–1.27,
<italic>p</italic>
= 0.35). Although the rs662 polymorphism reached a nominal level of significance, no polymorphism was significant after multiple testing correction. In the subanalysis of samples with genome-wide data from which population outliers were removed, rs662 had an OR of 1.06 (95% CI, 0.97–1.16,
<italic>p</italic>
= 0.22).</p>
</sec>
<sec>
<title>Conclusions:</title>
<p>In contrast to previous positive smaller studies, our genetic meta-analysis showed no significant association of amyotrophic lateral sclerosis (ALS) with the PON locus. This is the largest meta-analysis of a candidate gene in ALS to date and the first ALS meta-analysis to include data from whole genome association studies. The findings reinforce the need for much larger and more collaborative investigations of the genetic determinants of ALS.</p>
</sec>
<sec>
<title>GLOSSARY</title>
<def-list list-type="abr">
<def-item>
<term>
<bold>ALS</bold>
</term>
<def>
<p> = amyotrophic lateral sclerosis; </p>
</def>
</def-item>
<def-item>
<term>
<bold>CI</bold>
</term>
<def>
<p> = confidence interval; </p>
</def>
</def-item>
<def-item>
<term>
<bold>GWAS</bold>
</term>
<def>
<p> = genome-wide association studies; </p>
</def>
</def-item>
<def-item>
<term>
<bold>OR</bold>
</term>
<def>
<p> = odds ratio; </p>
</def>
</def-item>
<def-item>
<term>
<bold>SALS</bold>
</term>
<def>
<p> = sporadic ALS; </p>
</def>
</def-item>
<def-item>
<term>
<bold>SNP</bold>
</term>
<def>
<p> = single nucleotide polymorphism.</p>
</def>
</def-item>
</def-list>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurology</journal-id>
<journal-title>Neurology</journal-title>
<issn pub-type="ppub">0028-3878</issn>
<issn pub-type="epub">1526-632X</issn>
<publisher>
<publisher-name>American Academy of Neurology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">19321847</article-id>
<article-id pub-id-type="pmc">2707108</article-id>
<article-id pub-id-type="publisher-id">znl02509000016</article-id>
<article-id pub-id-type="doi">10.1212/WNL.0b013e3181a18674</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wills</surname>
<given-names>A -M.</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cronin</surname>
<given-names>S</given-names>
</name>
<degrees>PhD, MRCPI</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Slowik</surname>
<given-names>A</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kasperaviciute</surname>
<given-names>D</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Es</surname>
<given-names>M A.</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morahan</surname>
<given-names>J M.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valdmanis</surname>
<given-names>P N.</given-names>
</name>
<degrees>BSc</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meininger</surname>
<given-names>V</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melki</surname>
<given-names>J</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>C E.</given-names>
</name>
<degrees>MD, FRACP, FRCP</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rouleau</surname>
<given-names>G A.</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fisher</surname>
<given-names>E M.C.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>P J.</given-names>
</name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>K E.</given-names>
</name>
<degrees>DPhil</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pamphlett</surname>
<given-names>R</given-names>
</name>
<degrees>MD, FRACP</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van den Berg</surname>
<given-names>L H.</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Figlewicz</surname>
<given-names>D A.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andersen</surname>
<given-names>P M.</given-names>
</name>
<degrees>MD, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al-Chalabi</surname>
<given-names>A</given-names>
</name>
<degrees>PhD, FRCP</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hardiman</surname>
<given-names>O</given-names>
</name>
<degrees>MD, FRCPI</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Landers</surname>
<given-names>J E.</given-names>
</name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brown</surname>
<given-names>R H.</given-names>
<suffix>Jr</suffix>
</name>
<degrees>MD, DPhil</degrees>
</contrib>
</contrib-group>
<aff id="N0x20c2ae0N0x2e27190">Authors' affiliations are listed at the end of the article.
<break></break>
From the Cecil B. Day Neuromuscular Research Laboratory (A.-M.W., J.E.L., R.H.B.), Massachusetts General Hospital, Charlestown; Department of Neurology (S.C., O.H.), Beaumont Hospital, Dublin, Ireland; Department of Neurology (A.S.), Jagiellonian University, Krakow, Poland; Department of Neurodegenerative Disease (D.K., E.M.C.F.), UCL Institute of Neurology, London, UK; Netherlands ALS Center Department of Neurology (M.A.V.E., L.H.V.d.B.), Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands; The Stacey MND Laboratory (J.M.M., R.P.), Department of Pathology, The University of Sydney, Australia; Department of Molecular and Clinical Genetics (J.M.M.), Royal Prince Alfred Hospital, Australia; Center of Excellence in Neuromics (P.N.V., G.A.R.), University of Montreal, CHUM Research Center, and the Department of Medicine, University of Montreal, Canada; Centre Référent SLA (V.M.), Hôpital Salpêtrière, Paris, France; Department of Human Genetics (J.M.), Hadassah University Hospital, Jerusalem, Israel; MRC Centre for Neurodegeneration Research (C.E.S., A.A.-C.), King's College London, Department of Clinical Neuroscience, Institute of Psychiatry, London, UK; Academic Neurology Unit (P.J.S,), Medical School, University of Sheffield, UK; Department of Clinical Neurosciences (K.E.M.), Institute of Biomedical Research, The Medical School, University of Birmingham, UK; University of Michigan (D.A.F.), Ann Arbor, MI and the ALS Society of Canada; Department of Neurology (P.M.A.), Umeå University Hospital, Sweden; Trinity College Institute of Neuroscience (O.H.), Trinity College, Dublin, Ireland; and Center for Human Genetics Research, Richard B. Simches Research Building (S.P.), Massachusetts General Hospital, Boston, MA.
<break></break>
</aff>
<pub-date pub-type="ppub">
<day>7</day>
<month>7</month>
<year>2009</year>
</pub-date>
<volume>73</volume>
<issue>1</issue>
<fpage>16</fpage>
<lpage>24</lpage>
<copyright-statement>Copyright © 2009 by AAN Enterprises, Inc.</copyright-statement>
<abstract>
<sec>
<title>Background:</title>
<p>Six candidate gene studies report a genetic association of DNA variants within the paraoxonase locus with sporadic amyotrophic lateral sclerosis (ALS). However, several other large studies, including five genome-wide association studies, have not duplicated this finding.</p>
</sec>
<sec>
<title>Methods:</title>
<p>We conducted a meta-analysis of 10 published studies and one unpublished study of the paraoxonase locus, encompassing 4,037 ALS cases and 4,609 controls, including genome-wide association data from 2,018 ALS cases and 2,425 controls.</p>
</sec>
<sec>
<title>Results:</title>
<p>The combined fixed effects odds ratio (OR) for rs662 (PON1 Q192R) was 1.09 (95% confidence interval [CI], 1.02–1.16,
<italic>p</italic>
= 0.01); the genotypic OR for RR homozygotes at Q192R was 1.25 (95% CI, 1.07–1.45,
<italic>p</italic>
= 0.0004); the combined OR for rs854560 (PON1 L55M) was 0.97 (95% CI, 0.86–1.10,
<italic>p</italic>
= 0.62); the OR for rs10487132 (PON2) was 1.08 (95% CI, 0.92–1.27,
<italic>p</italic>
= 0.35). Although the rs662 polymorphism reached a nominal level of significance, no polymorphism was significant after multiple testing correction. In the subanalysis of samples with genome-wide data from which population outliers were removed, rs662 had an OR of 1.06 (95% CI, 0.97–1.16,
<italic>p</italic>
= 0.22).</p>
</sec>
<sec>
<title>Conclusions:</title>
<p>In contrast to previous positive smaller studies, our genetic meta-analysis showed no significant association of amyotrophic lateral sclerosis (ALS) with the PON locus. This is the largest meta-analysis of a candidate gene in ALS to date and the first ALS meta-analysis to include data from whole genome association studies. The findings reinforce the need for much larger and more collaborative investigations of the genetic determinants of ALS.</p>
</sec>
<sec>
<title>GLOSSARY</title>
<def-list list-type="abr">
<def-item>
<term>
<bold>ALS</bold>
</term>
<def>
<p> = amyotrophic lateral sclerosis; </p>
</def>
</def-item>
<def-item>
<term>
<bold>CI</bold>
</term>
<def>
<p> = confidence interval; </p>
</def>
</def-item>
<def-item>
<term>
<bold>GWAS</bold>
</term>
<def>
<p> = genome-wide association studies; </p>
</def>
</def-item>
<def-item>
<term>
<bold>OR</bold>
</term>
<def>
<p> = odds ratio; </p>
</def>
</def-item>
<def-item>
<term>
<bold>SALS</bold>
</term>
<def>
<p> = sporadic ALS; </p>
</def>
</def-item>
<def-item>
<term>
<bold>SNP</bold>
</term>
<def>
<p> = single nucleotide polymorphism.</p>
</def>
</def-item>
</def-list>
</sec>
</abstract>
</article-meta>
<notes>
<p>Address correspondence and reprint requests to Dr. Wills, CNY 114-3125, 114 16th St, Charlestown, MA 02129
<email>awills@partners.org</email>
.</p>
<p>Supplemental data at
<ext-link ext-link-type="uri" xlink:href="www.neurology.org">www.neurology.org</ext-link>
</p>
<p>Editorial, page 11.</p>
<p>
<italic>e-Pub ahead of print on March 25, 2009, at</italic>
<ext-link ext-link-type="uri" xlink:href="www.neurology.org">www.neurology.org</ext-link>
.</p>
<p>Support information is provided at the end of the article.</p>
<p>
<italic>Disclosure:</italic>
The authors report no disclosures.</p>
<p>
<italic>Devices:</italic>
GoldenGate assay, Illumina BeadArray station, Infinium II SNP Chip assays, Human Hap550K SNP chips, HumanHap 300K SNP chips (Illumina, San Diego, CA); KASPar PCR system (KBiosciences, Hertfordshire, UK); SNaPshot® assay (Applied Biosystems, Foster City, CA).</p>
<p>Received September 12, 2008. Accepted in final form January 5, 2009.</p>
</notes>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E93 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000E93 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:2707108
   |texte=   A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:19321847" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024